These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 1701315
1. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development. Neurath AR, Strick N, Taylor P, Rubinstein P, Stevens CE. AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1183-92. PubMed ID: 1701315 [Abstract] [Full Text] [Related]
4. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Koot M, Kuiken CL, Goudsmit J. Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319 [Abstract] [Full Text] [Related]
5. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1). Neurath AR, Strick N. Mol Immunol; 1990 Jun; 27(6):539-49. PubMed ID: 1696353 [Abstract] [Full Text] [Related]
8. Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160. Loomis LD, Deal CD, Kersey KS, Burke DS, Redfield RR, Birx DL. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):13-26. PubMed ID: 7544225 [Abstract] [Full Text] [Related]
9. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T. Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203 [Abstract] [Full Text] [Related]
14. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1). Neurath AR, Strick N, Jiang S. Virology; 1992 May 10; 188(1):1-13. PubMed ID: 1373549 [Abstract] [Full Text] [Related]
16. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. Jacob RA, Moyo T, Schomaker M, Abrahams F, Grau Pujol B, Dorfman JR. J Virol; 2015 May 10; 89(10):5264-75. PubMed ID: 25673728 [Abstract] [Full Text] [Related]
17. Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41. Matsuda S, Noda M. Microbiol Immunol; 2000 May 10; 44(11):923-9. PubMed ID: 11145273 [Abstract] [Full Text] [Related]